Literature DB >> 15774758

Type VII collagen is required for Ras-driven human epidermal tumorigenesis.

Susana Ortiz-Urda1, John Garcia, Cheryl L Green, Lei Chen, Qun Lin, Dallas P Veitch, Lynn Y Sakai, Hyangkyu Lee, M Peter Marinkovich, Paul A Khavari.   

Abstract

Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers. To study the role of collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1) were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII-null epidermis in a non-cell-autonomous fashion. Fibronectin-like sequences within NC1 (FNC1) promoted tumor cell invasion in a laminin 5-dependent manner and were required for tumorigenesis. Tumor-stroma interactions mediated by collagen VII thus promote neoplasia, and retention of NC1 sequences in a subset of RDEB patients may contribute to their increased susceptibility to squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774758     DOI: 10.1126/science.1106209

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  38 in total

1.  Species-specific fibroblasts required for triggering invasiveness of partially transformed oral keratinocytes.

Authors:  Daniela Elena Costea; Keerthi Kulasekara; Evelyn Neppelberg; Anne Christine Johannessen; Olav Karsten Vintermyr
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization.

Authors:  Bernd U Sehgal; Phillip J DeBiase; Sumio Matzno; Teng-Leong Chew; Jessica N Claiborne; Susan B Hopkinson; Alan Russell; M Peter Marinkovich; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2006-09-14       Impact factor: 5.157

3.  TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain.

Authors:  Li-Ting Su; Maria A Agapito; Mingjiang Li; William T N Simonson; Anna Huttenlocher; Raymond Habas; Lixia Yue; Loren W Runnels
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

Review 4.  Basement membranes in skin: unique matrix structures with diverse functions?

Authors:  Dirk Breitkreutz; Nicolae Mirancea; Roswitha Nischt
Journal:  Histochem Cell Biol       Date:  2009-03-31       Impact factor: 4.304

Review 5.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders.

Authors:  Mathew Varkey; Jie Ding; Edward E Tredget
Journal:  Tissue Eng Part A       Date:  2013-10-17       Impact factor: 3.845

7.  miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3.

Authors:  Ying Zhou; Jason Dang; Kung-Yen Chang; Edwin Yau; Pedro Aza-Blanc; Jorge Moscat; Tariq M Rana
Journal:  Cancer Res       Date:  2016-10-01       Impact factor: 12.701

8.  Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.

Authors:  Mary Ann Stepp; Sonali Pal-Ghosh; Gauri Tadvalkar; Lamise Rajjoub; Rosalyn A Jurjus; Michael Gerdes; Andrew Ryscavage; Christophe Cataisson; Anjali Shukla; Stuart H Yuspa
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

9.  Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.

Authors:  Jing Gao; Mindy C DeRouen; Chih-Hsin Chen; Michael Nguyen; Ngon T Nguyen; Hiroyuki Ido; Kenji Harada; Kiyotoshi Sekiguchi; Bruce A Morgan; Jeffery H Miner; Anthony E Oro; M Peter Marinkovich
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

Review 10.  Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy.

Authors:  G Chometon; V Jendrossek
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.